Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Cell Isolation/Separation Market worth $8.4 billion by 2029 driven by Growing Emphasis on Technological Advancements | MarketsandMarkets™.


News provided by

MarketsandMarkets

26 Jul, 2024, 14:30 GMT

Share this article

Share toX

Share this article

Share toX

CHICAGO, July 26, 2024 /PRNewswire/ -- The global Cell Isolation Market is expected to grow from USD 4.6 billion in 2024 to USD 8.4 billion by 2029, at a CAGR of 12.9%. The growth of the cell isolation market is driven by advancements in technology and the development of new, cost-effective, and user-friendly products. In recent years, key players have introduced innovative products such as Thermo Fisher Scientific's next-generation Gibco CTS Detachable Dynabeads, BD's FACSDiscover S8 cell sorter, and ALFA LAVAL's CultureOne Maxi, which are expected to boost adoption. Increased government funding for cell-based research, such as the recent $2.9 million grant from the National Institute of Neurological Disorders and Stroke to the University of Buffalo, supports the development of new treatments for chronic diseases. Additionally, the rising incidence of cancer and infectious diseases, alongside a focus on personalized medicine and next-generation therapeutics, is further propelling market growth. However, the market faces challenges such as the high cost of cell-based research and technical complexities in cell isolation methods, which can limit the capabilities of smaller labs and increase operational costs. The ecosystem comprises raw material suppliers, manufacturers, and end-users, with consumables leading the market in 2023. Adipose tissue was the dominant cell source due to its applications in tissue engineering and regenerative therapies. North America led the market, followed by Europe and Asia Pacific, due to its strong healthcare infrastructure and R&D investments. Key players in the market include Merck KGaA, Danaher Corporation, Thermo Fisher Scientific, BD, and others.

This image opens in the lightbox
MarketsandMarkets

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=103931479

Browse in-depth TOC on "Cell Isolation Market"

456 - Tables
62 - Figures
475 - Pages

DANAHER CORPORATION (US): Leader in Cell Separation and Analysis

Danaher Corporation emerged as a leader in the cell separation and analysis market due to its advanced technology, including greater automation and precise instrumentation. The company excels in improving cell separation reliability and efficiency, enabling researchers to achieve accurate results and accelerate breakthroughs in cellular biology. With a robust sales and distribution network, Danaher's strong market presence is supported by its Life Sciences and Biotechnology divisions, Beckman Coulter and Cytiva. The company focuses on inorganic growth strategies like partnerships, acquisitions, and expansions to enhance its market position. Notably, in March 2023, Danaher collaborated with the University of Pennsylvania to develop new technologies for improving clinical outcomes and addressing production constraints in next-generation cell therapies.

MERCK KGaA (Germany): Innovator in Cell Separation Kits and Reagents

In 2023, Merck KGaA distinguished itself with a broad range of high-quality kits and reagents for cell separation from complex sources. The company's commitment to innovation is evident in its state-of-the-art tools and technical support that ensure precise and efficient cell separation. Merck KGaA strengthens its market position through strategic partnerships and significant investments in research centers. For example, in April 2024, the company invested over USD 300 million in a new research center in Darmstadt, aimed at advancing solutions for mRNA applications, antibody synthesis, and biotechnological production, thereby enhancing its capabilities in cell-based technologies.

THERMO FISHER SCIENTIFIC INC. (US): Pioneer in Cell Isolation Solutions

Thermo Fisher Scientific Inc. maintains a leading position in the cell isolation market with its diverse product portfolio and extensive global presence. The company's focus on innovation is exemplified by products such as the Gibco CTS Detachable Dynabeads. Thermo Fisher supports research and clinical needs with scalable solutions and adaptable platforms. The company actively pursues partnerships and collaborations to advance its market reach. In February 2024, Thermo Fisher signed an agreement with Multiply Labs to automate the cell therapy manufacturing process, combining robotic technology with Thermo Fisher instruments to reduce costs, shorten manufacturing times, and improve scalability.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=103931479

Product Segmentation: Consumables Lead the Cell Isolation Market

The global cell isolation market is segmented by product into consumables and instruments. In 2023, consumables held the largest share of the market. This dominance is primarily due to the high demand for quality reagents that ensure reliable and reproducible results, the single-use nature of consumables leading to repetitive purchases, and advancements in cellular therapy and precision medicine. Additionally, increased investments in developing products such as magnetic beads and microfluidic chips, a growing number of regulatory approvals for new consumables, and rising government support for cell-based research contribute to the substantial growth of the consumables segment.

Cell Type Segmentation: Human Cells Dominate

The global cell isolation market is classified by cell type into animal cells and human cells, with human cells further subdivided into differentiated cells and stem cells. In 2023, the human cells segment led the market. This leadership is attributed to the extensive use of isolated differentiated human cells in research, academics, therapeutics, and biopharmaceutical & biotechnology industries. Key applications include isolating pure cell populations for biochemical analysis, using fluorescence-activated cell sorting (FACS) for specific cell types, and isolating stem cells from various sources for treatment processes.

Cell Source Segmentation: Adipose Tissue Holds the Largest Share

Based on cell source, the market is divided into adipose tissue, bone marrow, cord blood/embryonic stem cells, and other sources. In 2023, adipose tissue accounted for the largest share of the market. This segment includes various adherent cell populations such as adipose-derived stem/stromal cells (ASCs), adipose-derived adult stem cells (ADAS), and processed lipoaspirate (PLA) cells. The dominant share of adipose tissue is due to its increasing application in tissue engineering.

Technique Segmentation: Centrifugation-Based Isolation Leads

The cell isolation market is segmented by technique into centrifugation-based, surface marker-based, and filtration-based isolation. In 2023, centrifugation-based cell isolation held the largest share. This technique is widely used by biotech and biopharmaceutical companies, as well as clinical research organizations and academic institutes, for developing and manufacturing vaccines, enzymes, and antibodies. The segment's growth is driven by a focus on advanced biotherapeutics development.

Application Segmentation: Biomolecule Isolation Dominates

The market is categorized by application into biomolecule isolation, cancer research, stem cell research, tissue regeneration and regenerative medicine, in-vitro diagnostics, and others. In 2023, biomolecule isolation was the leading application. The large share is due to increasing demand for biopharmaceutical products, advancements in cell analysis techniques, and the growth of the global biopharmaceutical industry.

End-User Segmentation: Pharmaceutical & Biotechnology Companies Lead

The cell isolation market is segmented by end user into pharmaceutical & biotechnology companies, academic & research institutes, hospitals & diagnostic laboratories, and other users. In 2023, pharmaceutical and biotechnology companies dominated the market. This segment's large share is driven by the widespread adoption of advanced instruments for cell-based experiments and cancer research, as well as the growing number of R&D facilities globally.

Regional Insights: North America Holds the Largest Share

The global cell isolation market is divided into regions: North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America accounted for the largest share of the market. This is due to the region's focus on advanced cell-based therapies and healthcare infrastructure improvements. However, the Asia Pacific region is expected to be the fastest-growing market, driven by increasing research practices in biotechnology and life sciences and advancements in the biopharmaceutical industry.

For more information, inquire now! Inquire Now

Related Reports:

In Vitro Diagnostics Market

Single cell Analysis Market

Cell Culture Market

Infectious Disease Diagnostics Market

Cell Therapy Technologies Market

Get access to the latest updates on Cell Isolation Companies and Cell Isolation Market Share

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg

Modal title

Also from this source

MarketsandMarkets' 360Quadrants Recognizes Top Startups and SMEs in the Edge AI Software Quadrant Report 2025

MarketsandMarkets' 360Quadrants Recognizes Top Startups and SMEs in the Edge AI Software Quadrant Report 2025

360Quadrants has released its latest Edge AI Software Startups/SMEs Companies Assessment, 2025, recognizing key players, including both global giants ...

$7.80 Billion by 2030: Why Single-Use Surgical Instruments Are Reshaping Global Surgery | MarketsandMarkets™

$7.80 Billion by 2030: Why Single-Use Surgical Instruments Are Reshaping Global Surgery | MarketsandMarkets™

What's fueling the shift from sterilization to scalability? The global single-use surgical instruments market, valued at US$5.60 billion in 2024,...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Biotechnology

Biotechnology

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.